PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 717 of 767

Advanced search
🇺🇰Industrygenialcompliance.comTier 3 · Secondary coverage

Genial appoints Simon Peck as new Managing Director - Genial

Genial Genetics (Pathozoom AI)Original source
🌍Industryblueprintgenetics.comTier 1 · Company source

Blueprint Genetics further enhances the clinical utility of its testing offering with a major panel update

Blueprint Genetics (Quest Diagnostics)Original source
🇺🇰Industrygenialcompliance.comTier 3 · Secondary coverage

Mark Hawtin, Managing Director - Genial

Genial Genetics (Pathozoom AI)Original source
🇺🇰Industrygenialcompliance.comTier 3 · Secondary coverage

New joiners - Genial

Genial Genetics (Pathozoom AI)Original source
🌍Industryblueprintgenetics.comTier 1 · Company source

Blueprint Genetics and BioMarin collaborate to launch a sponsored testing program for individuals with skeletal dysplasia in Europe and the Middle East

Blueprint Genetics (Quest Diagnostics)Original source
🇬🇧Researchhdruk.ac.ukTier 2 · Direct publisher

Inspirational Speakers and Marshmallow Challenge

Health Data Research UKOriginal source
🇧🇷Researchfiocruz.brTier 2 · Direct publisher

Evento do Fórum de Editores Científicos da Fiocruz debate revisão por pares aberta

Fiocruz NewsOriginal source
🇺🇸Researchcidrap.umn.eduTier 2 · Direct publisher

News Scan for Oct 12, 2021

CIDRAPOriginal source
🇺🇰Industrygenialcompliance.comTier 3 · Secondary coverage

iPassport v3.6.0 coming soon - Genial

Genial Genetics (Pathozoom AI)Original source
🌍Industryblueprintgenetics.comTier 1 · Company source

Enhanced Access to Genetic Testing for Individuals with Auditory Neuropathy: The Resonate Program by Akouos Offers Healthcare Providers Online Ordering of Genetic Testing through Blueprint Genetics

Blueprint Genetics (Quest Diagnostics)Original source
🇺🇸Industrydyne-tx.comTier 1 · Company source

Loraine's Story - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🌍Industryblueprintgenetics.comTier 1 · Company source

New study in pediatric epilepsy supports the value of early genetic testing as a tool for making an accurate and an early diagnosis in children

Blueprint Genetics (Quest Diagnostics)Original source
🌍Industryblueprintgenetics.comTier 1 · Company source

Research collaboration aims to accelerate rare disease diagnostics by combining clinical information, machine learning algorithms, and genetic testing

Blueprint Genetics (Quest Diagnostics)Original source
🇧🇷Researchfiocruz.brTier 2 · Direct publisher

Nova disciplina transversal já disponível para PPGs e estudantes

Fiocruz NewsOriginal source
🌍Industryomniab.comTier 1 · Company source

Ligand’s Partner Gloria Biosciences Receives Approval in China for Zimberelimab for the Treatment of Recurrent or Refractory Classical Hodgkin’s Lymphoma

OmniAbOriginal source
🌍Industryguerbet.comTier 1 · Company source

The role of Health Information Technology in the optimization of patient outcomes and data management in modern healthcare organizations

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Reducing the “everyday challenge” of non-target embolization

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Réduire le risque quotidien de l’embolisation non ciblée

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

AI in Life Sciences - Seeing Past the Hype

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

L'IA appliquée aux sciences de la vie : au-delà du phénomène de mode

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

When you join Guerbet, you’ve chosen a human scale, worldwide leader

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

En rejoignant Guerbet, vous choisissez un leader mondial à taille humaine

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Guerbet signe un accord avec icometrix pour la commercialisation exclusive d’icobrain, une solution d’imagerie médicale d’intelligence artificielle, pour l’imagerie cérébrale

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging | Guerbet

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Guerbet et IBM Watson Health annoncent un deuxième projet de codéveloppement dans le cadre de leur partenariat stratégique alliant l’intelligence artificielle à l’imagerie médicale | Guerbet

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

2018 revenue

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Chiffre d’affaires 2018

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

2019 half-year results

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Résultats semestriels 2019

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Revenue at 30 June 2019

GuerbetOriginal source
🌍Industryguerbet.comTier 1 · Company source

Chiffre d’affaires au 30 juin 2019

GuerbetOriginal source
🇧🇷Researchfiocruz.brTier 2 · Direct publisher

Em espanhol: política de gestão, compartilhamento e abertura de dados para pesquisa tem nova versão

Fiocruz NewsOriginal source
🇧🇷Researchfiocruz.brTier 2 · Direct publisher

A pluralidade da ciência aberta é tema de debate do Centro de Estudos do Icict

Fiocruz NewsOriginal source
🌍Industryomniab.comTier 1 · Company source

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb Licensing Agreement

OmniAbOriginal source
🌍Industryblueprintgenetics.comTier 1 · Company source

The My Retina Tracker Genetic Testing Program Continues to Expand with Spark Therapeutics Joining as New Collaborator

Blueprint Genetics (Quest Diagnostics)Original source
🇺🇸Industrydyne-tx.comTier 1 · Company source

FORCE Video - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸Industrydyne-tx.comTier 1 · Company source

Finding Strength Beyond Muscle - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🇺🇸Industrydyne-tx.comTier 1 · Company source

Perspectives Article - Dyne Therapeutics

Dyne TherapeuticsOriginal source
🌍Industryblueprintgenetics.comTier 1 · Company source

Quest Diagnostics and Blueprint Genetics to Present New Insights from Genetic Testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting

Blueprint Genetics (Quest Diagnostics)Original source
🇺🇸Researchcidrap.umn.eduTier 2 · Direct publisher

COVID-19 Scan for Apr 06, 2021

CIDRAPOriginal source
🇧🇷Researchfiocruz.brTier 2 · Direct publisher

Acesse a Política de Gestão, Compartilhamento e Abertura de Dados para Pesquisa da Fiocruz

Fiocruz NewsOriginal source
🇨🇦Researchucalgary.caTier 2 · Direct publisher

Parlez-vous français?

University of CalgaryOriginal source
🇨🇦Researchucalgary.caTier 2 · Direct publisher

UCalgary Political Science interviews our colleague and Associate Dean, Internationalization and Global Affairs, Dr. Gavin Cameron

University of CalgaryOriginal source
🌍Industrypetros.comTier 1 · Company source

Hint-of-Orange Iced Tea® — Petros® Love at First Bite

Petros PharmaceuticalsOriginal source
🇺🇰Industryorchard-tx.comTier 1 · Company source

Patient Engagement in the Era of Gene Therapy

Orchard TherapeuticsOriginal source
🌍Industryproqr.comTier 1 · Company source

Expert Perspectives Series - Disease Education and Endpoints in Usher Syndrome

ProQROriginal source
🌍Industryblueprintgenetics.comTier 1 · Company source

New study finds evidence indicating the NRAP gene to be a significant cause of recessive dilated cardiomyopathy

Blueprint Genetics (Quest Diagnostics)Original source
🌍Industrycervomed.comTier 1 · Company source

EIP Pharma Announces Positive Phase 2 Results for Neflamapimod in Mild-to-Moderate Dementia with Lewy bodies (DLB) - CervoMed

CervoMedOriginal source
🌍Industrycervomed.comTier 1 · Company source

EIP Pharma Announces Presentation of Positive Clinical Trial Results with Neflamapimod at the 13th Clinical Trials in Alzheimer’s Disease (CTAD) Meeting - CervoMed

CervoMedOriginal source
🌍Industrycervomed.comTier 1 · Company source

EIP Pharma Announces Publication of Preclinical Results Demonstrating Potential of Neflamapimod to Promote Functional Recovery after Ischemic Stroke - CervoMed

CervoMedOriginal source
🇨🇦Mediainnovativemedicines.caTier 2 · Direct publisher

MEET THE EXPERTS: JOE FARAGO

Innovative Medicines CanadaOriginal source
🇺🇰Industryorchard-tx.comTier 1 · Company source

Reflecting on the Past Year, Looking Toward New Horizons

Orchard TherapeuticsOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Centres de vaccination contre la Covid-19

Hospices Civils de LyonOriginal source
🇺🇰Industryorchard-tx.comTier 1 · Company source

An Open Letter of Gratitude

Orchard TherapeuticsOriginal source
🌍Industryproqr.comTier 1 · Company source

HC Wainwright Virtual BIOCONNECT 2021 Conference

ProQROriginal source
🇨🇦Researchucalgary.caTier 2 · Direct publisher

Bridging the gap between veterinary and human musculoskeletal health

University of CalgaryOriginal source
🇺🇰Industryorchard-tx.comTier 1 · Company source

My engagement and leadership at Orchard and why it’s important

Orchard TherapeuticsOriginal source
🇨🇦Researchucalgary.caTier 2 · Direct publisher

Social work researcher to help create national plan to stop violence against women

University of CalgaryOriginal source
🌍Industryomniab.comTier 1 · Company source

Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb Antibodies

OmniAbOriginal source
🌍Industryproqr.comTier 1 · Company source

3rd Annual Evercore ISI Virtual HealthCONx Conference

ProQROriginal source